UCLA Health
myUCLAhealth
School of Medicine
Toggle navigation
About Us
What is UCLA Health?
Contact Us
Your Feedback
Accountable Care Organization
Awards & Achievements
Careers
Careers for Physicians
Departments - Administrative
Departments - Clinical
Industry Relations
In the Community
Innovation & Technology
Leadership
News Releases
Social Media
Contact
Your Feedback
Accountable Care Organization
Awards and Achievements
Careers
Careers for Physicians
Departments - Administrative
Departments - Clinical
Industry Relations
In the Community
Innovation & Technology
Leadership
News Releases
Social Media
Conditions & Treatment
Health Library
Tests & Procedures
Drug Interaction Checker
Brain & Nervous System
Cancer
Children's Health
Heart Disease
Nutrition & Wellness
Pregnancy & Newborns
Orthopedics
Women's Health
Video Library
Cancer
Cardiovascular
Chiropractic
Cosmetic Surgery
Ear, Nose and Throat
Gastrointestinal
General Healthcare
Neurological
Obstetrics/Gynecology
See all videos...
Video Library
Locations
Hospitals
Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica
UCLA Mattel Children's Hospital
Resnick Neuropsychiatric Hospital
Institutes and Centers
Take a Virtual Tour
Medical Offices/Clinics
Primary Care
Specialty Care
Urgent Care Centers
Outpatient Surgery Centers
Imaging/Radiology Locations
Clinical Labs
Pharmacies
Coming Soon
Interactive Map
UCLA Hospitals
Take a Virtual Tour
Primary Care Practices
Specialty Care Practices
Urgent Care Centers
Outpatient Surgery Centers
Other Locations
Interactive Map
Coming Soon!
Medical Services
For Patients & Visitors
Directions & Parking
Appointments: Call, Click, Come In
Admissions Information
Preparing For Surgery
Patient Services
Security & Parking Services
Office of the Patient Experience
For International Patients
Lodging & Nearby Services
Around Westwood
Gift Shops & Flowers
Health Resources
Log in to myUCLAhealth
About myUCLAhealth
Billing Information
Medical Records
Accountable Care Organization (ACO)
Covered California
Health Plans
Interactive Patient Education Videos (Emmi)
FAQ
s
Calendar of Events
Share Your Story
Health Publications
Vital Signs Newsletters
Health Tips for Parents
Contact Us
Appointments: Call, Click, Come in
Admissions Information
Advance Directive
Covered California
Health Plans
Directions & Parking
Patient Services
Medical Records
myUCLAhealth
Smoke-Free
Publications
Health Resources
Around Westwood
Lodging
Preparing For Surgery
Patient-focused Technology Council
Health Forms
End of Life Option Act: Resources & Materials
Frequently Asked Questions
Gift Shops
For Healthcare Professionals
Referring a Patient
E-Referral
Continuing Medical Education
Ethics Center
UCLA HealthLink
Physician to Physician Access Line (P2P)
David Geffen School of Medicine at UCLA
Clinical Informatics Fellowship
Academic Positions
Physician Careers
UCLA School of Nursing
Department of Nursing
Physician Publications
Physicians Update
Clinical Updates
U Magazine
E-Referral
Physician to Physician Access Line (P2P)
Physician Careers
Clinical Informatics Fellowship
Flu Resources for Healthcare Professionals
Publications
Multimedia
UCLAMDCHAT Webinars
Community Health Program Videos
UCLAORLive Surgery
iTunes
Download Our Apps
Mini Med School
Demystifying Cancer Forum
TEDx UCLA Videos
Tips from our Physical Therapists
Patient Stories
Real Questions
Webinars on Demand
Pediatric Grand Rounds
Community Health Program Videos
UCLAORLive Surgery
UCLAMDChat Webinars
iTunes
Download Our Apps
Mini Med School
Demystifying Cancer Forum
TEDx UCLA Videos
Tips From Our Physical Therapists
Patient Stories
Real Questions
Back Pain Management
Find a Provider
UCLA Health
myUCLAhealth
School of Medicine
About Us
About Us
About Us
Contact
Your Feedback
Accountable Care Organization
CMS Medicare Shared Savings Program
UCLA MSSP ACO
ACO - Anthem Blue Cross PPO
Anthem Blue Cross PPO ACO FAQ
Awards and Achievements
UCLA Health hospitals rank among nation’s best in U.S. News survey
UCLA Designated a National Magnet Hospital
Careers
Careers for Physicians
Departments - Administrative
Departments - Clinical
Industry Relations
In the Community
Community Health
Innovation & Technology
Contact
Leadership
Dr. John Mazziotta
Johnese Spisso
Dr. Kelsey Martin
News Releases
Social Media
About Us
Contact
Your Feedback
Accountable Care Organization
Awards and Achievements
Careers
Careers for Physicians
Departments - Administrative
Departments - Clinical
Industry Relations
In the Community
Innovation & Technology
Leadership
News Releases
Social Media
Home
About Us
News Releases
News Releases
Share this
Health and Behavior
Study finds cholesterol regulator plays key role in development of liver scarring, cirrhosis
03/30/2011
UCLA researchers have demonstrated that a key regulator of cholesterol and fat metabolism in the liver also plays an important role in the development of liver fibrosis — the build-up of collagen scar tissue that can develop into cirrhosis. Cirrhosis, in turn, is a major cause of premature death and is incurable without a liver transplant.
Published in the March issue of the journal Gastroenterology, the study shows that liver X receptors (LXRs), master regulators of cholesterol, fat and inflammatory gene expression, also control the fibrosis-making cells of the liver, known as hepatic stellate cells.
In the face of chronic liver injury — due to excess fat, chronic viral hepatitis or alcohol abuse, for example — stellate cells become activated and launch an inflammatory and fibrotic cascade that eventually results in the build-up of collagen scar tissue in the liver.
LXRs, when stimulated, "turn on" several hundred genes that hold instructions to create proteins for carrying out bodily processes in cells, from transporting and excreting cholesterol to synthesizing fat in the liver. They have also been shown to suppress inflammatory processes in several contexts.
"Our work sets the stage for looking at new ways to modulate cholesterol and/or fat metabolism in order to have therapeutic potential for the treatment of fibrosing liver diseases," said lead author Dr. Simon Beaven, an assistant professor of digestive diseases at the David Geffen School of Medicine at UCLA.
The research was done in the laboratory of senior author Dr. Peter Tontonoz, a professor of pathology and laboratory medicine at the Geffen School of Medicine and a Howard Hughes Medical Institute investigator.
Beaven noted that the recent rise in obesity has resulted in a surge in the prevalence of a condition known as fatty liver, which can be a precursor to fibrosis and chronic liver disease. Simple fatty liver, also known as non-alcoholic fatty liver disease, or NAFLD, is one of the most common reasons patients consult a liver doctor in the United States. Cirrhosis due to fatty liver is skyrocketing and within a decade may become the most common indication for liver transplantation.
Beaven said the need to find better treatments for liver disease is crucial.
"A 'holy grail' for liver researchers is to develop anti-fibrotic treatments that target activated stellate cells in order to slow or prevent the development of cirrhosis," Beaven said. "Our study offers the first detailed look at how LXRs specifically impact the activation of hepatic stellate cells and the subsequent development of liver fibrosis in animal models."
UCLA researchers have found that LXRs normally play a role in helping to reduce the collagen-producing actions of stellate cells when the cells are "activated" by liver damage. For the study, UCLA scientists first tested how activated stellate cells taken from mice would react when a chemical that induces LXR activity was added to the cell culture.
In stellate cells from normal mice, LXRs suppressed the inflammatory and fibrosis-promoting program. But in those taken from mice genetically lacking LXRs, that same program of genes significantly increased because the inhibitory effect of LXRs was no longer present.
"We showed that LXRs dampen stellate cell activation by repressing inflammatory and collagen-producing genes," Beaven said.
To further gauge the strength of the response, scientists took the medium from the cultures of LXR-deficient cells and added it to stellate cells from normal mice. These cells then showed a markedly exaggerated inflammatory and collagen-producing response, suggesting that LXR-deficient stellate cells are secreting signals to promote fibrosis.
The researchers noted that these experiments demonstrate that LXRs control a fibrotic response in stellate cells that can have a wide influence on neighboring cells.
The scientists also found that after replicating chronic liver injury, mice without LXRs had dramatically more liver fibrosis than normal mice.
"The genetic loss of LXRs rendered the mice susceptible to developing fibrotic liver disease," Beaven said.
But LXRs are also known to have important functions in the immune system. The researchers then wanted to know whether the effects they were seeing in animals were due to changes in stellate cell activity specifically or whether immune cells — derived from bone marrow — accounted for most of the effect. After extensive testing, the researchers found no differences in the level of liver fibrosis among normal mice and animals lacking LXRs, suggesting that the contribution from the immune system was negligible.
"This finding, along with the cell culture studies, suggests that LXRs' influence on fibrosis most likely resides in altering stellate cell function in the liver," Beaven said. "This is a critical finding and opens an entire new field of study for stellate cell biologists."
Additional studies will further identify which genes in stellate cells are activated by LXRs and help researchers better understand the role of cholesterol metabolism in the fibrotic response.
This study was funded primarily by grants from the National Institutes of Health and the Howard Hughes Medical Institute. Collaborators from the University of Southern California were funded by core grants from the NIH and the Southern California Research Center for ALPD and Cirrhosis.
Other study authors included senior investigator Dr. Peter Tontonoz of the Howard Hughes Medical Institute; Kevin Wroblewski and Cynthia Hong from Tontonoz's lab; Jiaohong Wang and Hide Tsukamoto of the Southern California Research Center for ALPD and Cirrhosis, USC's Keck School of Medicine and the Department of Veterans Affairs Greater Los Angeles Healthcare System; and Steven Bensinger of the department of pathology at the David Geffen School of Medicine at UCLA.
For more news, visit the
UCLA Newsroom
and follow us on
Twitter
.
Media Contact:
Rachel Champeau
(310) 794-2270
rchampeau@mednet.ucla.edu
Media Contact
Rachel Champeau
(310) 794-2270
rchampeau@mednet.ucla.edu
Latest News
Health and Behavior
Crop choices: How price supports can contribute to healthier diets
04/19/2018
Professor's model suggests well-designed subsidies can help farmers and give consumers better food choices.
Health and Behavior
UCLA study reports nearly 1 in 3 California kids have a sugary drink daily
04/19/2018
Research confirms that one sugary drink a day can increase people’s risk for Type 2 diabetes, liver disease, tooth decay and obesity.
Health and Behavior
Two UCLA professors elected to American Academy of Arts and Sciences
04/18/2018
Philippe Bourgouis and Rosa Matzkin join the organization of scholars, artists and innovators, which was founded in 1780.
Health and Behavior
Researchers link sedentary behavior to thinning in brain region critical for memory
04/16/2018
Researchers link sedentary behavior to thinning in a brain region that is critical for memory.
Health and Behavior
UCLA study produces clearest images to date of HSV-1, the virus that causes cold sores
04/13/2018
Researchers used cryo electron microscopy to obtain the first atomic model of the particle, which is made up of more than 3,000 protein molecules comprising tens of millions of atoms.
Like Us on Facebook
Follow Us on Twitter
Subscribe to Our Videos on YouTube
Follow us on Instagram
Add Us to Your Google+ Circles
Connect with Us on LinkedIn
Follow us on Pinterest
Follow us on Flickr
Follow us on Sharecare
×
Sign in to myUCLAhealth